|drug173||Aerobic training Wiki||1.00|
|D012127||Respiratory Distress Syndrome, Newborn NIH||0.08|
|D055371||Acute Lung Injury NIH||0.08|
|D012128||Respiratory Distress Syndrome, Adult NIH||0.07|
There is one clinical trial.
This study will be conducted on eighty patients of both sexes with age ranging from 35 to 45years. The will be recovered from COVID-19 infection with chest symptoms. They will be selected from Nasr city police authority hospital. They will be randomly assigned into 3 equal groups.
Description: A venous blood sample will be taken to be analyzed in the laboratoryMeasure: Complete blood picture Time: change from baseline at 6 weeks
Description: arterial blood sample will be assessedMeasure: Arterial blood gases Time: change from baseline at 6 weeks
Description: patient will be instructed to walk as fast as long as possible, in a 30 meters obstacle- free corridor, limited by turnaround cones. Standardized verbal encouragement will be given every minute. After 6 min, patient will be instructed to stop, and the total distance will be measured, rounding to the nearest meter.Measure: 6-minute walk Distance Time: change from baseline at 6 weeks
Description: A rough index of cardiopulmonary reserve measured by the length of time that a person can voluntarily stop breathing; normal duration is 30 seconds or longer; diminished cardiac or pulmonary reserve is indicated by a duration of 20 seconds or less.Measure: Breath-hold test Time: change from baseline at 6 weeks
Description: Percentage of haemoglobin saturated with oxygen measured by pulse oximeterMeasure: Oxygen saturation Time: change from baseline at 6 weeks
Description: It is a 0 to 10 rated numerical score used to measure dyspnea as reported by the patient during six minute walk testMeasure: Borg Dyspnea Scale score Time: change from baseline at 6 weeks
Description: Maximum oxygen consumption(VO2 max): Results of (6MWT) was used to calculate Vo2 max by using Cahalin equation as follows; Vo2 max = 0.03x distance in meters +3.98, in which distance is obtained from (6MWT)Measure: Maximum oxygen consumption Time: change from baseline at 6 weeks
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports